{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:22:36Z","timestamp":1791606156193,"version":"4.3.4"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006742","name":"Cooperativa de Ensino Superior Polit\u00e9cnico e Universit\u00e1rio","doi-asserted-by":"publisher","award":["GLIMFOX_GI2-CESPU-2025"],"award-info":[{"award-number":["GLIMFOX_GI2-CESPU-2025"]}],"id":[{"id":"10.13039\/501100006742","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","award":["2020.06611.BD"],"award-info":[{"award-number":["2020.06611.BD"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s13346-025-02019-z","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T17:42:24Z","timestamp":1764870144000},"page":"761-779","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Nanocarrier-based intranasal drug delivery for enhanced neurological disorders treatment"],"prefix":"10.1007","volume":"16","author":[{"given":"Eva","family":"Morim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5763-7553","authenticated-orcid":false,"given":"Bruno","family":"Sarmento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"2019_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2022.07.003","author":"R Awad","year":"2023","unstructured":"Awad R, Avital A, Sosnik A. Polymeric nanocarriers for nose-to-brain drug delivery in neurodegenerative diseases and neurodevelopmental disorders. Acta Pharm Sin B. 2023. https:\/\/doi.org\/10.1016\/j.apsb.2022.07.003","journal-title":"Acta Pharm Sin B"},{"key":"2019_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2023.12.054","author":"Q Huang","year":"2024","unstructured":"Huang Q, Chen Y, Zhang W, Xia X, Li H, Qin M, et al. Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases. J Control Release. 2024. https:\/\/doi.org\/10.1016\/j.jconrel.2023.12.054","journal-title":"J Control Release"},{"key":"2019_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115196","author":"Y Chen","year":"2024","unstructured":"Chen Y, Zhang C, Huang Y, Ma Y, Song Q, Chen H, et al. Intranasal drug delivery: the interaction between nanoparticles and the nose-to-brain pathway. Adv Drug Deliv Rev. 2024. https:\/\/doi.org\/10.1016\/j.addr.2024.115196","journal-title":"Adv Drug Deliv Rev"},{"key":"2019_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124866","author":"R Upadhyay","year":"2024","unstructured":"Upadhyay R, Ghosh P, Desavathu M. Advancement in the Nose-to-Brain drug delivery of FDA-approved drugs for the better management of depression and psychiatric disorders. Int J Pharm. 2024. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124866","journal-title":"Int J Pharm"},{"key":"2019_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.02.012","author":"CP Costa","year":"2021","unstructured":"Costa CP, Moreira JN, Sousa Lobo JM, Silva AC. Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies. Acta Pharm Sin B. 2021. https:\/\/doi.org\/10.1016\/j.apsb.2021.02.012","journal-title":"Acta Pharm Sin B"},{"key":"2019_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2018.05.009","author":"V Bourganis","year":"2018","unstructured":"Bourganis V, Kammona O, Alexopoulos A, Kiparissides C. Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics. Eur J Pharm Biopharm. 2018. https:\/\/doi.org\/10.1016\/j.ejpb.2018.05.009","journal-title":"Eur J Pharm Biopharm"},{"key":"2019_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebr.2022.100581","author":"S Chung","year":"2023","unstructured":"Chung S, Peters JM, Detyniecki K, Tatum W, Rabinowicz AL, Carrazana E. The nose has it: opportunities and challenges for intranasal drug administration for neurologic conditions including seizure clusters. Epilepsy Behav Rep. 2023. https:\/\/doi.org\/10.1016\/j.ebr.2022.100581","journal-title":"Epilepsy Behav Rep"},{"key":"2019_CR8","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.5c00297","author":"S Rezaee","year":"2025","unstructured":"Rezaee S, Al-Majdoub ZM, Galetin A, Rostami-Hodjegan A, Ogungbenro K. Challenges and opportunities for incorporating physiological information into Pharmacokinetic models of intranasal drug delivery to the brain: A review of the current status and future trajectories. Mol Pharm. 2025. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5c00297","journal-title":"Mol Pharm"},{"key":"2019_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2018.12.049","author":"C Costa","year":"2019","unstructured":"Costa C, Moreira JN, Amaral MH, Sousa Lobo JM, Silva AC. Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis. J Control Release. 2019. https:\/\/doi.org\/10.1016\/j.jconrel.2018.12.049","journal-title":"J Control Release"},{"key":"2019_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13122049","author":"D Lee","year":"2021","unstructured":"Lee D, Minko T. Nanotherapeutics for Nose-to-Brain drug delivery: an approach to bypass the blood brain barrier. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13122049","journal-title":"Pharmaceutics"},{"key":"2019_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10030116","author":"S G\u00e4nger","year":"2018","unstructured":"G\u00e4nger S, Schindowski K. Tailoring formulations for intranasal Nose-to-Brain delivery: A review on Architecture, Physico-Chemical characteristics and mucociliary clearance of the nasal olfactory mucosa. Pharmaceutics. 2018. https:\/\/doi.org\/10.3390\/pharmaceutics10030116","journal-title":"Pharmaceutics"},{"key":"2019_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2022.08.210","author":"S Ahmad","year":"2022","unstructured":"Ahmad S, Khan I, Pandit J, Emad NA, Bano S, Dar KI, et al. Brain targeted delivery of carmustine using Chitosan coated nanoparticles via nasal route for glioblastoma treatment. Int J Biol Macromol. 2022. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.08.210","journal-title":"Int J Biol Macromol"},{"key":"2019_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2017.01.031","author":"G Rassu","year":"2017","unstructured":"Rassu G, Soddu E, Posadino AM, Pintus G, Sarmento B, Giunchedi P, et al. Nose-to-brain delivery of BACE1 SiRNA loaded in solid lipid nanoparticles for alzheimer\u2019s therapy. Colloids Surf B Biointerfaces. 2017. https:\/\/doi.org\/10.1016\/j.colsurfb.2017.01.031","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2019_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202203182","author":"X Yang","year":"2022","unstructured":"Yang X, Yang W, Xia X, Lei T, Yang Z, Jia W, et al. Intranasal delivery of BACE1 SiRNA and Rapamycin by dual targets modified nanoparticles for alzheimer\u2019s disease therapy. Small. 2022. https:\/\/doi.org\/10.1002\/smll.202203182","journal-title":"Small"},{"key":"2019_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2013.11.049","author":"C Zhang","year":"2014","unstructured":"Zhang C, Chen J, Feng C, Shao X, Liu Q, Zhang Q, et al. Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat alzheimer\u2019s disease. Int J Pharm. 2014. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.11.049","journal-title":"Int J Pharm"},{"key":"2019_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2017.12.006","author":"PI Chater","year":"2018","unstructured":"Chater PI, Wilcox MD, Pearson JP. Efficacy and safety concerns over the use of mucus modulating agents for drug delivery using nanoscale systems. Adv Drug Deliv Rev. 2018. https:\/\/doi.org\/10.1016\/j.addr.2017.12.006","journal-title":"Adv Drug Deliv Rev"},{"key":"2019_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2025.02.035","author":"Y Xu","year":"2025","unstructured":"Xu Y, Ye X, Du Y, Yang W, Tong F, Li W, et al. Nose-to-brain delivery of targeted lipid nanoparticles as two-pronged \u03b2-amyloid nanoscavenger for alzheimer\u2019s disease therapy. Acta Pharm Sin B. 2025. https:\/\/doi.org\/10.1016\/j.apsb.2025.02.035","journal-title":"Acta Pharm Sin B"},{"key":"2019_CR18","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.4c08279","author":"G Wang","year":"2024","unstructured":"Wang G, Zhai Z, Wang W, Xia X, Guo H, Yue X, et al. Tailored Borneol-Modified lipid nanoparticles nasal spray for enhanced Nose-to-Brain delivery to central nervous system diseases. ACS Nano. 2024. https:\/\/doi.org\/10.1021\/acsnano.4c08279","journal-title":"ACS Nano"},{"key":"2019_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2024.09.039","author":"X Yue","year":"2025","unstructured":"Yue X, Guo H, Wang G, Li J, Zhai Z, Wang Z, et al. A tailored phytosomes based nose-to-brain drug delivery strategy: silver bullet for alzheimer\u2019s disease. Bioactive Mater. 2025. https:\/\/doi.org\/10.1016\/j.bioactmat.2024.09.039","journal-title":"Bioactive Mater"},{"key":"2019_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201902906","author":"H Yang","year":"2020","unstructured":"Yang H, Mu W, Wei D, Zhang Y, Duan Y, Gao JX, et al. A novel targeted and High-Efficiency nanosystem for combinational therapy for alzheimer\u2019s disease. Adv Sci (Weinh). 2020. https:\/\/doi.org\/10.1002\/advs.201902906","journal-title":"Adv Sci (Weinh)"},{"key":"2019_CR21","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.3c08756","author":"J Li","year":"2023","unstructured":"Li J, Peng H, Zhang W, Li M, Wang N, Peng C, et al. Enhanced Nose-to-Brain delivery of combined small interfering RNAs using Lesion-Recognizing nanoparticles for the synergistic therapy of alzheimer\u2019s disease. ACS Appl Mater Interfaces. 2023. https:\/\/doi.org\/10.1021\/acsami.3c08756","journal-title":"ACS Appl Mater Interfaces"},{"key":"2019_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.06.053","author":"L Kozlovskaya","year":"2014","unstructured":"Kozlovskaya L, Abou-Kaoud M, Stepensky D. Quantitative analysis of drug delivery to the brain via nasal route. J Control Release. 2014. https:\/\/doi.org\/10.1016\/j.jconrel.2014.06.053","journal-title":"J Control Release"},{"key":"2019_CR23","doi-asserted-by":"publisher","unstructured":"Nguyen TT, Duong VA. Advancements in Nanocarrier Systems for Nose-to-Brain Drug Delivery. Pharmaceuticals (Basel). 2025. https:\/\/doi.org\/10.3390\/ph18050615","DOI":"10.3390\/ph18050615"},{"key":"2019_CR24","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.S93937","author":"AK Al Asmari","year":"2016","unstructured":"Al Asmari AK, Ullah Z, Tariq M, Fatani A. Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil. Drug Des Devel Ther. 2016. https:\/\/doi.org\/10.2147\/dddt.S93937","journal-title":"Drug Des Devel Ther"},{"key":"2019_CR25","doi-asserted-by":"publisher","DOI":"10.1080\/08982104.2024.2336549","author":"KB Khot","year":"2024","unstructured":"Khot KB, Gopan DSS, Deshpande G, Shastry NS, Bandiwadekar P. Enhancing selegiline hydrochloride efficacy: box Behnken-optimized liposomal delivery via intranasal route for parkinson\u2019s disease intervention. J Liposome Res. 2024. https:\/\/doi.org\/10.1080\/08982104.2024.2336549","journal-title":"J Liposome Res"},{"key":"2019_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17020243","author":"AA Katamesh","year":"2025","unstructured":"Katamesh AA, Abdel-Bar HM, Break MKB, Hassoun SM, Subaiea GM, Radwan A, et al. Tailored intranasal albumin caged Selegiline-\u03b1 synuclein SiRNA liposome with improved efficiency in parkinson\u2019s model. Pharmaceutics. 2025. https:\/\/doi.org\/10.3390\/pharmaceutics17020243","journal-title":"Pharmaceutics"},{"key":"2019_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14030572","author":"TT Nguyen","year":"2022","unstructured":"Nguyen TT, Maeng HJ. Pharmacokinetics and pharmacodynamics of intranasal solid lipid nanoparticles and nanostructured lipid carriers for Nose-to-Brain delivery. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14030572","journal-title":"Pharmaceutics"},{"key":"2019_CR28","doi-asserted-by":"publisher","DOI":"10.3109\/10717544.2014.880860","author":"R Bhatt","year":"2015","unstructured":"Bhatt R, Singh D, Prakash A, Mishra N. Development, characterization and nasal delivery of Rosmarinic acid-loaded solid lipid nanoparticles for the effective management of huntington\u2019s disease. Drug Deliv. 2015. https:\/\/doi.org\/10.3109\/10717544.2014.880860","journal-title":"Drug Deliv"},{"key":"2019_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125197","author":"HA Nematalla","year":"2025","unstructured":"Nematalla HA, Elharoun M, Bargash SN, Abd-Alhaseeb MM, Sharafeldin HA, Zewail M, et al. Novel Nose-to-brain delivery of Carbenoxolone via mucoadhesive solid lipid nanoparticles for parkinson\u2019s symptoms management: in vitro and in vivo evaluation in a rotenone-induced rat model. Int J Pharm. 2025. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125197","journal-title":"Int J Pharm"},{"key":"2019_CR30","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.S15881","author":"S Eskandari","year":"2011","unstructured":"Eskandari S, Varshosaz J, Minaiyan M, Tabbakhian M. Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model. Int J Nanomed. 2011. https:\/\/doi.org\/10.2147\/ijn.S15881","journal-title":"Int J Nanomed"},{"key":"2019_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15061593","author":"C Viegas","year":"2023","unstructured":"Viegas C, Patr\u00edcio AB, Prata JM, Nadhman A, Chintamaneni PK, Fonte P. Solid lipid nanoparticles vs. Nanostructured Lipid Carriers: Comp Rev Pharm. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15061593","journal-title":"Nanostructured Lipid Carriers: Comp Rev Pharm"},{"key":"2019_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-017-0728-7","author":"S Hernando","year":"2018","unstructured":"Hernando S, Herran E, Figueiro-Silva J, Pedraz JL, Igartua M, Carro E, et al. Intranasal administration of TAT-Conjugated lipid nanocarriers loading GDNF for parkinson\u2019s disease. Mol Neurobiol. 2018. https:\/\/doi.org\/10.1007\/s12035-017-0728-7","journal-title":"Mol Neurobiol"},{"key":"2019_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1214450","author":"Y Xinchen","year":"2023","unstructured":"Xinchen Y, Jing T, Jiaoqiong G. Lipid-based nanoparticles via nose-to-brain delivery: a mini review. Front Cell Dev Biol. 2023. https:\/\/doi.org\/10.3389\/fcell.2023.1214450","journal-title":"Front Cell Dev Biol"},{"key":"2019_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/6640103","author":"SS Preeti","year":"2023","unstructured":"Preeti SS, Malik R, Bhatia S, Al Harrasi A, Rani C, et al. Nanoemulsion: an emerging novel technology for improving the bioavailability of drugs. Scientifica (Cairo). 2023. https:\/\/doi.org\/10.1155\/2023\/6640103","journal-title":"Scientifica (Cairo)"},{"key":"2019_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2382563","author":"B Gaba","year":"2019","unstructured":"Gaba B, Khan T, Haider MF, Alam T, Baboota S, Parvez S, et al. Vitamin E loaded naringenin nanoemulsion via intranasal delivery for the management of oxidative stress in a 6-OHDA parkinson\u2019s disease model. Biomed Res Int. 2019. https:\/\/doi.org\/10.1155\/2019\/2382563","journal-title":"Biomed Res Int"},{"key":"2019_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105842","author":"A Salama","year":"2024","unstructured":"Salama A, Soliman GM, Elsherbiny N, Safwat MA. Chitosan-coated nanoemulsion for the direct nose-to-brain delivery of sildenafil: development and in vivo evaluation in a brain oxidative stress and inflammation model. J Drug Deliv Sci Technol. 2024. https:\/\/doi.org\/10.1016\/j.jddst.2024.105842","journal-title":"J Drug Deliv Sci Technol"},{"key":"2019_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2022.11.013","author":"L Tang","year":"2023","unstructured":"Tang L, Zhang R, Wang Y, Zhang X, Yang Y, Zhao B, et al. A simple self-assembly nanomicelle based on brain tumor-targeting peptide-mediated SiRNA delivery for glioma immunotherapy via intranasal administration. Acta Biomater. 2023. https:\/\/doi.org\/10.1016\/j.actbio.2022.11.013","journal-title":"Acta Biomater"},{"key":"2019_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2021.12.034","author":"Y Yang","year":"2022","unstructured":"Yang Y, Zhang X, Wu S, Zhang R, Zhou B, Zhang X, et al. Enhanced nose-to-brain delivery of SiRNA using hyaluronan-enveloped nanomicelles for glioma therapy. J Control Release. 2022. https:\/\/doi.org\/10.1016\/j.jconrel.2021.12.034","journal-title":"J Control Release"},{"key":"2019_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-024-01528-7","author":"MM Ibrahim","year":"2024","unstructured":"Ibrahim MM, Basalious EB, El-Nabarawi MA, Makhlouf AI, Sayyed ME, Ibrahim IT. Nose to brain delivery of Mirtazapine via lipid nanocapsules: Preparation, statistical optimization, radiolabeling, in vivo biodistribution and Pharmacokinetic study. Drug Deliv Transl Res. 2024. https:\/\/doi.org\/10.1007\/s13346-024-01528-7","journal-title":"Drug Deliv Transl Res"},{"key":"2019_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202500598","author":"Y Jia","year":"2025","unstructured":"Jia Y, Xu L, Leng S, Sun Y, Huang X, Wang Y, et al. Nose-to\u2010Brain delivery of circular RNA SCMH1\u2010Loaded lipid nanoparticles for ischemic stroke therapy. Adv Mater. 2025. https:\/\/doi.org\/10.1002\/adma.202500598","journal-title":"Adv Mater"},{"key":"2019_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29153482","author":"F Eker","year":"2024","unstructured":"Eker F, Duman H, Akda\u015f\u00e7i E, Bolat E, Sar\u0131ta\u015f S, Karav S, et al. A comprehensive review of nanoparticles: from classification to application and toxicity. Molecules. 2024. https:\/\/doi.org\/10.3390\/molecules29153482","journal-title":"Molecules"},{"key":"2019_CR42","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.3c00705","author":"MA Beach","year":"2024","unstructured":"Beach MA, Nayanathara U, Gao Y, Zhang C, Xiong Y, Wang Y, et al. Polymeric nanoparticles for drug delivery. Chem Rev. 2024. https:\/\/doi.org\/10.1021\/acs.chemrev.3c00705","journal-title":"Chem Rev"},{"key":"2019_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119046","author":"F Wang","year":"2020","unstructured":"Wang F, Yang Z, Liu M, Tao Y, Li Z, Wu Z, et al. Facile nose-to-brain delivery of rotigotine-loaded polymer micelles thermosensitive hydrogels: in vitro characterization and in vivo behavior study. Int J Pharm. 2020. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119046","journal-title":"Int J Pharm"},{"key":"2019_CR44","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2016.1223216","author":"SA Nour","year":"2016","unstructured":"Nour SA, Abdelmalak NS, Naguib MJ, Rashed HM, Ibrahim AB. Intranasal brain-targeted clonazepam polymeric micelles for immediate control of status epilepticus: in vitro optimization, ex vivo determination of cytotoxicity, in vivo biodistribution and pharmacodynamics studies. Drug Deliv. 2016. https:\/\/doi.org\/10.1080\/10717544.2016.1223216","journal-title":"Drug Deliv"},{"key":"2019_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10020493","author":"RNL Lamptey","year":"2022","unstructured":"Lamptey RNL, Gothwal A, Trivedi R, Arora S, Singh J. Synthesis and characterization of fatty acid grafted Chitosan polymeric micelles for improved gene delivery of VGF to the brain through intranasal route. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10020493","journal-title":"Biomedicines"},{"key":"2019_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25163731","author":"A Zieli\u0144ska","year":"2020","unstructured":"Zieli\u0144ska A, Carreir\u00f3 F, Oliveira AM, Neves A, Pires B, Venkatesh DN, et al. Polymeric nanoparticles: Production, Characterization, toxicology and ecotoxicology. Molecules. 2020. https:\/\/doi.org\/10.3390\/molecules25163731","journal-title":"Molecules"},{"key":"2019_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.138336","author":"S Chakraborty","year":"2025","unstructured":"Chakraborty S, Karmakar V, Chatterjee K, Chatterjee A, Dwivedi M, Gorain B. Chitosan nanoparticle-mediated nose-to-brain delivery of naringenin: attenuating memory decline in experimental animals via behavioural assessment and modulation of biochemical parameters. Int J Biol Macromol. 2025. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138336","journal-title":"Int J Biol Macromol"},{"key":"2019_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2017.12.056","author":"R Raj","year":"2018","unstructured":"Raj R, Wairkar S, Sridhar V, Gaud R. Pramipexole dihydrochloride loaded Chitosan nanoparticles for nose to brain delivery: Development, characterization and in vivo anti-Parkinson activity. Int J Biol Macromol. 2018. https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.12.056","journal-title":"Int J Biol Macromol"},{"key":"2019_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/s10876-023-02528-2","author":"Y Garg","year":"2024","unstructured":"Garg Y, Kumar M, Sharma G, Katare OP, Chopra S, Bhatia A. Systematic designing and optimization of polymeric nanoparticles using central composite design: A novel approach for Nose-to-Brain delivery of donepezil hydrochloride. J Cluster Sci. 2024. https:\/\/doi.org\/10.1007\/s10876-023-02528-2","journal-title":"J Cluster Sci"},{"key":"2019_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.106857","author":"M Kouhjani","year":"2025","unstructured":"Kouhjani M, Jaafari MR, Saberi A, Gholami L, Tafaghodi M. Nose to brain delivery of insulin loaded in PLGA and chitosan-coated PLGA nanoparticles: A promising approach for alzheimer\u2019s disease therapy. J Drug Deliv Sci Technol. 2025. https:\/\/doi.org\/10.1016\/j.jddst.2025.106857","journal-title":"J Drug Deliv Sci Technol"},{"key":"2019_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajps.2017.09.001","author":"S Liu","year":"2018","unstructured":"Liu S, Yang S, Ho PC. Intranasal administration of carbamazepine-loaded carboxymethyl Chitosan nanoparticles for drug delivery to the brain. Asian J Pharm Sci. 2018. https:\/\/doi.org\/10.1016\/j.ajps.2017.09.001","journal-title":"Asian J Pharm Sci"},{"key":"2019_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2018.11.002","author":"T Musumeci","year":"2018","unstructured":"Musumeci T, Serapide MF, Pellitteri R, Dalpiaz A, Ferraro L, Dal Magro R, et al. Oxcarbazepine free or loaded PLGA nanoparticles as effective intranasal approach to control epileptic seizures in rodents. Eur J Pharm Biopharm. 2018. https:\/\/doi.org\/10.1016\/j.ejpb.2018.11.002","journal-title":"Eur J Pharm Biopharm"},{"key":"2019_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/polym15224369","author":"M P\u00e9rez-Ferreiro","year":"2023","unstructured":"P\u00e9rez-Ferreiro M, A MA, Criado A, G\u00f3mez IJ, Mosquera J, Dendrimers. Exploring their wide structural variety and applications. Polym (Basel). 2023. https:\/\/doi.org\/10.3390\/polym15224369","journal-title":"Polym (Basel)"},{"key":"2019_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25173982","author":"AA Chis","year":"2020","unstructured":"Chis AA, Dobrea C, Morgovan C, Arseniu AM, Rus LL, Butuca A, et al. Applications and limitations of dendrimers in biomedicine. Molecules. 2020. https:\/\/doi.org\/10.3390\/molecules25173982","journal-title":"Molecules"},{"key":"2019_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2025.01.036","author":"Y Jia","year":"2025","unstructured":"Jia Y, Kong X, Li R, Wang H, Li C, Cheng S, et al. Enhanced nasal-to-brain drug delivery by multivalent bioadhesive nanoparticle clusters for cerebral ischemic reperfusion injury protection. Acta Biomater. 2025. https:\/\/doi.org\/10.1016\/j.actbio.2025.01.036","journal-title":"Acta Biomater"},{"key":"2019_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202216097","author":"J Kaltbeitzel","year":"2023","unstructured":"Kaltbeitzel J, Wich PR. Protein-based nanoparticles: from drug delivery to Imaging, nanocatalysis and protein therapy. Angew Chem Int Ed Engl. 2023. https:\/\/doi.org\/10.1002\/anie.202216097","journal-title":"Angew Chem Int Ed Engl"},{"key":"2019_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12070604","author":"S Hong","year":"2020","unstructured":"Hong S, Choi DW, Kim HN, Park CG, Lee W, Park HH. Protein-Based nanoparticles as drug delivery systems. Pharmaceutics. 2020. https:\/\/doi.org\/10.3390\/pharmaceutics12070604","journal-title":"Pharmaceutics"},{"key":"2019_CR58","doi-asserted-by":"publisher","DOI":"10.1111\/jphp.12836","author":"LR Wong","year":"2018","unstructured":"Wong LR, Ho PC. Role of serum albumin as a nanoparticulate carrier for nose-to-brain delivery of R-flurbiprofen: implications for the treatment of alzheimer\u2019s disease. J Pharm Pharmacol. 2018. https:\/\/doi.org\/10.1111\/jphp.12836","journal-title":"J Pharm Pharmacol"},{"key":"2019_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148848","author":"YZ Zhao","year":"2016","unstructured":"Zhao YZ, Jin RR, Yang W, Xiang Q, Yu WZ, Lin Q, et al. Using gelatin nanoparticle mediated intranasal delivery of neuropeptide substance P to enhance Neuro-Recovery in Hemiparkinsonian rats. PLoS ONE. 2016. https:\/\/doi.org\/10.1371\/journal.pone.0148848","journal-title":"PLoS ONE"},{"key":"2019_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2020.102246","author":"E Joachim","year":"2020","unstructured":"Joachim E, Barakat R, Lew B, Kim KK, Ko C, Choi H. Single intranasal administration of 17\u03b2-estradiol loaded gelatin nanoparticles confers neuroprotection in the post-ischemic brain. Nanomedicine. 2020. https:\/\/doi.org\/10.1016\/j.nano.2020.102246","journal-title":"Nanomedicine"},{"key":"2019_CR61","doi-asserted-by":"publisher","unstructured":"Zhu Y, Zhu Y, Cao T, Liu X, Liu X, Yan Y et al. Ferritin-based nanomedicine for disease treatment. Med Rev. 2021;2023. https:\/\/doi.org\/10.1515\/mr-2023-0001","DOI":"10.1515\/mr-2023-0001"},{"key":"2019_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06653-2","author":"F Marrocco","year":"2024","unstructured":"Marrocco F, Falvo E, Mosca L, Tisci G, Arcovito A, Reccagni A, et al. Nose-to-brain selective drug delivery to glioma via ferritin-based nanovectors reduces tumor growth and improves survival rate. Cell Death Dis. 2024. https:\/\/doi.org\/10.1038\/s41419-024-06653-2","journal-title":"Cell Death Dis"},{"key":"2019_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119957","author":"E Gallardo-Toledo","year":"2020","unstructured":"Gallardo-Toledo E, Tapia-Arellano A, Celis F, Sinai T, Campos M, Kogan MJ, et al. Intranasal administration of gold nanoparticles designed to target the central nervous system: fabrication and comparison between nanospheres and nanoprisms. Int J Pharm. 2020. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119957","journal-title":"Int J Pharm"},{"key":"2019_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202504517","author":"S Han","year":"2025","unstructured":"Han S, Utami RN, Qin Y, Liam-Or R, Sreedharan J, Davies JS, et al. Nose-to-Brain delivery of Acyl-Ghrelin peptide gold nanoconjugates for treatment of neurodegenerative diseases. Small. 2025. https:\/\/doi.org\/10.1002\/smll.202504517","journal-title":"Small"},{"key":"2019_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119342","author":"UK Sukumar","year":"2019","unstructured":"Sukumar UK, Bose RJC, Malhotra M, Babikir HA, Afjei R, Robinson E, et al. Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic MicroRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to Temozolomide. Biomaterials. 2019. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119342","journal-title":"Biomaterials"},{"key":"2019_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2017.07.023","author":"JW Guo","year":"2017","unstructured":"Guo JW, Guan PP, Ding WY, Wang SL, Huang XS, Wang ZY, et al. Erythrocyte membrane-encapsulated celecoxib improves the cognitive decline of alzheimer\u2019s disease by concurrently inducing neurogenesis and reducing apoptosis in APP\/PS1 Transgenic mice. Biomaterials. 2017. https:\/\/doi.org\/10.1016\/j.biomaterials.2017.07.023","journal-title":"Biomaterials"},{"key":"2019_CR67","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.4c16837","author":"NN Ferreira","year":"2025","unstructured":"Ferreira NN, Leite CM, Moreno NS, Miranda RR, Pincela Lins PM, Rodero CF, et al. Nose-to-Brain delivery of biomimetic nanoparticles for glioblastoma targeted therapy. ACS Appl Mater Interfaces. 2025. https:\/\/doi.org\/10.1021\/acsami.4c16837","journal-title":"ACS Appl Mater Interfaces"},{"key":"2019_CR68","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.5c06051","author":"C Wang","year":"2025","unstructured":"Wang C, Feng W, Li J, Wang J, Liu L, Ye SH, et al. Enhanced Nano-Vaccine utilizing biomineralized Virus-like particles for efficient glioblastoma immunotherapy via the Nose-To-Brain delivery pathway. ACS Nano. 2025. https:\/\/doi.org\/10.1021\/acsnano.5c06051","journal-title":"ACS Nano"},{"key":"2019_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.01.013","author":"S Ruan","year":"2024","unstructured":"Ruan S, Li J, Ruan H, Xia Q, Hou X, Wang Z, et al. Microneedle-mediated nose-to-brain drug delivery for improved alzheimer\u2019s disease treatment. J Control Release. 2024. https:\/\/doi.org\/10.1016\/j.jconrel.2024.01.013","journal-title":"J Control Release"},{"key":"2019_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.04.047","author":"J Gon\u00e7alves","year":"2019","unstructured":"Gon\u00e7alves J, Bicker J, Gouveia F, Liberal J, Oliveira RC, Alves G, et al. Nose-to-brain delivery of Levetiracetam after intranasal administration to mice. Int J Pharm. 2019. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.04.047","journal-title":"Int J Pharm"},{"key":"2019_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910357","author":"D Lee","year":"2024","unstructured":"Lee D, Shen AM, Shah M, Garbuzenko OB, Minko T. In vivo evaluation of Nose-to-Brain delivery of liposomal Donepezil, Memantine, and BACE-1 SiRNA for alzheimer\u2019s disease therapy. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms251910357","journal-title":"Int J Mol Sci"},{"key":"2019_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15010221","author":"MG Shivananjegowda","year":"2023","unstructured":"Shivananjegowda MG, Hani U, Osmani RAM, Alamri AH, Ghazwani M, Alhamhoom Y, et al. Development and evaluation of solid lipid nanoparticles for the clearance of A\u03b2 in alzheimer\u2019s disease. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15010221","journal-title":"Pharmaceutics"},{"key":"2019_CR73","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2019.1593439","author":"GM Jojo","year":"2019","unstructured":"Jojo GM, Kuppusamy G, De A, Karri V. Formulation and optimization of intranasal nanolipid carriers of Pioglitazone for the repurposing in alzheimer\u2019s disease using Box-Behnken design. Drug Dev Ind Pharm. 2019. https:\/\/doi.org\/10.1080\/03639045.2019.1593439","journal-title":"Drug Dev Ind Pharm"},{"key":"2019_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemphyslip.2020.104917","author":"A Arora","year":"2020","unstructured":"Arora A, Kumar S, Ali J, Baboota S. Intranasal delivery of tetrabenazine nanoemulsion via olfactory region for better treatment of hyperkinetic movement associated with huntington\u2019s disease: Pharmacokinetic and brain delivery study. Chem Phys Lipids. 2020. https:\/\/doi.org\/10.1016\/j.chemphyslip.2020.104917","journal-title":"Chem Phys Lipids"},{"key":"2019_CR75","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.1c07587","author":"K Wang","year":"2021","unstructured":"Wang K, Kumar US, Sadeghipour N, Massoud TF, Paulmurugan RA, Microfluidics-Based. Scalable approach to generate extracellular vesicles with enhanced therapeutic MicroRNA loading for intranasal delivery to mouse glioblastomas. ACS Nano. 2021. https:\/\/doi.org\/10.1021\/acsnano.1c07587","journal-title":"ACS Nano"},{"key":"2019_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.bionps.2024.100104","author":"MZ Price","year":"2024","unstructured":"Price MZ, Price RL. Benefits and risks of Esketamine nasal spray continuation in treatment-resistant depression. Biomarkers Neuropsychiatry. 2024. https:\/\/doi.org\/10.1016\/j.bionps.2024.100104. https:\/\/doi.org\/.","journal-title":"Biomarkers Neuropsychiatry"},{"key":"2019_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2018.05.011","author":"M Agrawal","year":"2018","unstructured":"Agrawal M, Saraf S, Saraf S, Antimisiaris SG, Chougule MB, Shoyele SA, et al. Nose-to-brain drug delivery: an update on clinical challenges and progress towards approval of anti-Alzheimer drugs. J Control Release. 2018. https:\/\/doi.org\/10.1016\/j.jconrel.2018.05.011","journal-title":"J Control Release"},{"key":"2019_CR78","doi-asserted-by":"publisher","DOI":"10.1001\/archpediatrics.2010.130","author":"M Holsti","year":"2010","unstructured":"Holsti M, Dudley N, Schunk J, Adelgais K, Greenberg R, Olsen C, et al. Intranasal Midazolam vs rectal diazepam for the home treatment of acute seizures in pediatric patients with epilepsy. Arch Pediatr Adolesc Med. 2010. https:\/\/doi.org\/10.1001\/archpediatrics.2010.130","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2019_CR79","doi-asserted-by":"publisher","DOI":"10.1111\/epi.17441","author":"J French","year":"2023","unstructured":"French J, Biton V, Dave H, Detyniecki K, Gelfand MA, Gong H, et al. A randomized phase 2b efficacy study in patients with seizure episodes with a predictable pattern using Staccato\u00ae Alprazolam for rapid seizure termination. Epilepsia. 2023. https:\/\/doi.org\/10.1111\/epi.17441","journal-title":"Epilepsia"},{"key":"2019_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/bs8050051","author":"I Pedroso","year":"2018","unstructured":"Pedroso I, Garcia M, Casabona E, Morales L, Bringas ML, P\u00e9rez L, et al. Protective activity of erythropoyetine in the cognition of patients with parkinson\u2019s disease. Behav Sci (Basel). 2018. https:\/\/doi.org\/10.3390\/bs8050051","journal-title":"Behav Sci (Basel)"},{"key":"2019_CR81","doi-asserted-by":"publisher","DOI":"10.37757\/mr2021.V23.N1.10","author":"M Garc\u00eda-Llano","year":"2021","unstructured":"Garc\u00eda-Llano M, Pedroso-Ib\u00e1\u00f1ez I, Morales-Chac\u00f3n L, Rodr\u00edguez-Obaya T, P\u00e9rez-Ruiz L, Sosa-Test\u00e9 I, et al. Short-term tolerance of Nasally-administered neuroepo in patients with Parkinson disease. MEDICC Rev. 2021. https:\/\/doi.org\/10.37757\/mr2021.V23.N1.10","journal-title":"MEDICC Rev"},{"key":"2019_CR82","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.1840","author":"S Craft","year":"2020","unstructured":"Craft S, Raman R, Chow TW, Rafii MS, Sun CK, Rissman RA, et al. Safety, Efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and alzheimer disease dementia: A randomized clinical trial. JAMA Neurol. 2020. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1840","journal-title":"JAMA Neurol"},{"key":"2019_CR83","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-021-00845-7","author":"M Rosenbloom","year":"2021","unstructured":"Rosenbloom M, Barclay TR, Kashyap B, Hage L, O\u2019Keefe LR, Svitak A, et al. A phase II, Single-Center, Randomized, Double-Blind, Placebo-Controlled study of the safety and therapeutic efficacy of intranasal Glulisine in amnestic mild cognitive impairment and probable mild alzheimer\u2019s disease. Drugs Aging. 2021. https:\/\/doi.org\/10.1007\/s40266-021-00845-7","journal-title":"Drugs Aging"},{"key":"2019_CR84","doi-asserted-by":"publisher","DOI":"10.1111\/acem.14422","author":"DS Tsze","year":"2022","unstructured":"Tsze DS, Lubell TR, Carter RC, Chernick LS, DePeter KC, McLaren SH, et al. Intranasal ketorolac versus intravenous ketorolac for treatment of migraine headaches in children: A randomized clinical trial. Acad Emerg Med. 2022. https:\/\/doi.org\/10.1111\/acem.14422","journal-title":"Acad Emerg Med"},{"key":"2019_CR85","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0608611104","author":"SK Lai","year":"2007","unstructured":"Lai SK, O\u2019Hanlon DE, Harrold S, Man ST, Wang YY, Cone R, et al. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc Natl Acad Sci U S A. 2007. https:\/\/doi.org\/10.1073\/pnas.0608611104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.07.045","author":"M Yang","year":"2014","unstructured":"Yang M, Lai SK, Yu T, Wang YY, Happe C, Zhong W, et al. Nanoparticle penetration of human cervicovaginal mucus: the effect of Polyvinyl alcohol. J Control Release. 2014. https:\/\/doi.org\/10.1016\/j.jconrel.2014.07.045","journal-title":"J Control Release"},{"key":"2019_CR87","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c09273","author":"AJ Pickering","year":"2023","unstructured":"Pickering AJ, Lamson NG, Marand MH, Hwang W, Straehla JP, Hammond PT. Layer-by-Layer polymer functionalization improves nanoparticle penetration and glioblastoma targeting in the brain. ACS Nano. 2023. https:\/\/doi.org\/10.1021\/acsnano.3c09273","journal-title":"ACS Nano"},{"key":"2019_CR88","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1304504110","author":"J Zhou","year":"2013","unstructured":"Zhou J, Patel TR, Sirianni RW, Strohbehn G, Zheng MQ, Duong N, et al. Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma. Proc Natl Acad Sci U S A. 2013. https:\/\/doi.org\/10.1073\/pnas.1304504110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019_CR89","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003594","author":"EA Nance","year":"2012","unstructured":"Nance EA, Woodworth GF, Sailor KA, Shih TY, Xu Q, Swaminathan G, et al. A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue. Sci Transl Med. 2012. https:\/\/doi.org\/10.1126\/scitranslmed.3003594","journal-title":"Sci Transl Med"},{"key":"2019_CR90","doi-asserted-by":"publisher","DOI":"10.1021\/nn504210g","author":"E Nance","year":"2014","unstructured":"Nance E, Zhang C, Shih TY, Xu Q, Schuster BS, Hanes J. Brain-penetrating nanoparticles improve Paclitaxel efficacy in malignant glioma following local administration. ACS Nano. 2014. https:\/\/doi.org\/10.1021\/nn504210g","journal-title":"ACS Nano"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-02019-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-02019-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-02019-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T15:22:01Z","timestamp":1770304921000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-02019-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2019"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-02019-z","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethical approval or consent to participate was required to this review paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to the publication of this review article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}